HALISTER: One Hit in Hand, Alexion Tries to Repeat After $8.4 Billion Deal

One Hit in Hand, Alexion Tries to Repeat After $8.4 Billion Deal

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
ALXN US (Alexion Pharmaceuticals Inc)
GEVA US (Synageva BioPharma Corp)

People
David Hallal (Alexion Pharmaceuticals Inc)
Leonard Bell (Alexion Pharmaceuticals Inc)
Stefan Quenneville (Morningstar Inc)

Topics
CEO Interviews

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283